Insight Molecular Diagnostics Investor Relations Material
Latest events
Status Update
Insight Molecular Diagnostics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Insight Molecular Diagnostics Inc
Access all reports
OncoCyte Corporation develops and markets molecular diagnostics for use in oncology and transplantation. The company focuses on liquid biopsy technologies and gene expression testing to support clinical decision-making in patient care. Its services are aimed at healthcare providers and research institutions. The company is headquartered in Irvine, California, and its shares are listed on the NASDAQ.
Key slides for Insight Molecular Diagnostics Inc
Investor Presentation
Insight Molecular Diagnostics Inc
Investor Presentation
Insight Molecular Diagnostics Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
IMDX
Country
🇺🇸 United States